Asymmetric syntheses of (2S,3S,6S)-, (2S,3S,6R)-, and (2R,3R,6S)-2,3-methano-2,6-diaminopimelic acids. Studies directed to the design of novel substrate-based inhibitors of L,L-diaminopimelate epimerase

Tetrahedron

Volumn 52, Issue 4, 1996, Pages 1149-1164

  Williams, Robert M ^a   Fegley, Glenn J ^a   Gallegos, Reneé ^a   Schaefer, Felicity ^b   Pruess, David L ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIAMINO 2,3 METHANOPIMELIC ACID; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; EPIMERASE; PIMELIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; ENANTIOMER; ENZYME INHIBITION; ESCHERICHIA COLI; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REACTION ANALYSIS;

ESCHERICHIA COLI;

EID: 0030052848     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(95)00976-0     Document Type: Article

References (51)

1. Taken in part from the Ph.D. Thesis of G.J.F., Colorado State University, 1994.
2. Wiseman, J. S.; Nichols, J. S. J. Biol. Chem. 1984, 259, 8907.
3. Antia, M.; Hoare, D. S.; Work, E. Biochem. J. 1957, 65, 448.
4. a) Fischer, L. M.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2538.
5. b) Fisher, L. M.; Belasco, J. G.; Bruice, T. W.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2543.
6. c) Belasco, J. G.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2552.
7. d) Belasco, J. G.; Bruice, T. W.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2558.
8. e) Belasco, J. G.; Bruice, T. W.; Fisher, L. M.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2564.
9. f) Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2572.
10. Compounds 1 - 4,6 are the most potent DAP epimerase inhibitors known to date: a) Baumann, R. J.; Bohme, E. H.; Wiseman, J. S.; Vaal, M.; Nichols, J. S. Antimicrob. Agents Chemother. 1988, 32, 1119.
11. b) Lam, L. K. P.; Arnold, L. D.; Kalantar, T. H.; Kelland, J. G.; Lane-Bell, P. M.; Palcic, M. M.; Pickard, M. A.; Vederas, J. C. J. Biol. Chem. 1988, 263, 11814.
12. c) Gerhart, F.; Higgins, W.; Tardif, C.; Ducep, J-B. J. Med. Chem. 1990, 33, 2157
13. d) Gelb, M. H.; Lin, Y.; Pickard, M. A.; Song, Y.; Vederas, J. C. J. Am. Chem. Soc. 1990, 112, 4932.
14. There is some precedence for ring opening of activated cyclopropanes by thiolate nucleophiles. See: a) Kondo, K.; Umemoto, T.; Takahatake, Y.; Tunemoto, D. Tetrahedron Lett. 1977, 113.
15. b) Zutterman, E.; DeWilde, H.; Mingheer, R.; De Clercq, P.; Vandevalle, H. Tetrahedron Lett. 1979, 35, 2389.
16. c) Isobe, M.; Iio, H.; Kawai, T.; Goto, T. J. Am. Chem. Soc. 1978, 100, 1940.
17. d) Iio, H.; Isobe, M.; Kawai, T.; Goto, T. J. Am. Chem. Soc. 1979, 101, 6076.
18. d) Iio, H.; Isobe, M.; Kawai, T.; Goto, T. Tetrahedron 1979, 35, 941.
19. For enzyme-mediated nucleophilic ring opening reactions of activated cyclopropanes, see: e) Walsh, C. T.; Pascal, R. A., Jr.; Johnston, M.; Raines, R.; Dikshit, D.; Krantz, A.; Honma, M. Biochemistry, 1981, 20, 7509.
20. f) Hill, R. K.; Prakash, S. R.; Wiesendanger, R.; Angst, W.; Martinoni, B.; Arigoni, D.; Walsh, C. T.; Liu, H-W. J. Am. Chem. Soc. 1984, 106, 795.
21. g) Liu, H-W.; Auchus, R.; Walsh, C. T. J. Am. Chem. Soc. 1984, 106, 5335.
22. Williams, R. M.; Im, M-N.; Cao, J. J. Am. Chem. Soc. 1991, 173, 6976.
23. Baldwin, J. E.; Lee, V.; Schofield, C. J. Syn. Lett. 1992, 249.
24. Shoji, J.; Hinoo, H.; Kato, T.; Nakauchi, K.; Matsuura, S.; Mayama, M.; Yasuda, Y.; Kawamura, Y. J. Antibiot. 1981, 34, 374.
25. Williams, R. M.; Yuan, C. J. Org. Chem. 1992, 57, 6519.
26. a) Sinclair, P. J.; Zhai, D.; Riebenspies, J.; Williams, R. M. J. Am. Chem. Soc. 1986, 108, 1103.
27. b) Williams, R. M.; Sinclair, P. J.; Zhai, D.; Chen, D. J. Am. Chem. Soc. 1988, 110, 1547.
28. c) Sinclair, P. J. Ph.D. Thesis, Colorado State University, 1987;
29. d) Williams, R. M.; Zhai, D.; Sincair, P. J. J. Org. Chem. 1986, 51, 5021;
30. e) Williams, R. M.; Sinclair, P. J.; Zhai, W. J. Am. Chem. Soc. 1988, 110, 482;
31. f) Williams, R. M.; Zhai, W. Tetrahedron 1988, 44, 5425.
32. g) Zhai, D.; Zhai, W.; Williams, R. M. J. Am. Chem. Soc. 1988, 110, 2501;
33. h) Williams, R. M.; Hendrix, J. A. J. Org. Chem. 1990, 55, 3723.
34. a) Williams, R. M.; Im, M-N. Tetrahedron Lett. 1989, 29, 6075.
35. b) Williams, R. M.; Im, M-N. J. Am. Chem. Soc. 1991, 113, 9276.
36. Williams, R. M.; Fegley, G. J. J. Am. Chem. Soc. 1991, 113, 8796.
37. a) Johnson, C. R.; Janiga, E. R.; Haake, M. J. Am. Chem. Soc. 1968, 90, 3890.
38. b) Johnson, C. R.; Schroeck, C. W. J. Am. Chem. Soc. 1968, 90, 6852.
39. c) Johnson, C. R.; Haake, M.; Schroeck, C. W. J. Am. Chem. Soc. 1970, 92, 6594.
40. d) Johnson, C. R.; Schroeck, C. W. J. Am. Chem. Soc. 1973, 95, 7418.
41. e) Johnson, C. R.; Schroeck, C. W.; Shanklin, J. R. J. Am. Chem. Soc. 1973, 95, 7424.
42. f) Johnson, C. R.; Janiga, E. R. J. Am. Chem. Soc. 1973, 95, 7692.
43. g) Johnson, C. R.; Rogers, P. E. J. Org. Chem. 1973, 38, 1793.
44. h) Johnson, C. R.; Rogers, P. E. J. Org. Chem. 1973, 38, 1798.
45. For a comprehensive review on the synthetic applications of sulfoximines, see: Johnson, C. R. Aldrichimica Acta 1985, 18, 3.
46. 13 shows convincing evidence for analogous stereochemical outcomes in the cyclopropanation reaction.
47. a)Berges, D. A.; DeWolf Jr., W. E.; Dunn, G. L.; Grappel, S. F.; Newman, D. J.; Taggart, J. J.; Gilvarg, C. J. Med. Chem. 1986, 29, 89.
48. b)Bauer, A.W.; Kirby, W.M.M.; Sherris, J.C.; Turck, M., Am.J.Clin. Pathol. 1966, 45, 493;
49. c)Song, Y.; Neiderer, D.; Lane-Bell, P. M.; Lam, L. K. P.; Crawley, S.; Palcic, M. M.; Pickard, M. A.; Pruess, D. L.; Vederas, J. C. J. Org. Chem. 1994, 59, 5784.
50. d)Mirelman, D. Y.; Yashouv-Gan, Y.; Schwarz, U. Biochemistry 1976, 15, 1781.
51. e)Moore, B. A.; Jevons, S.; Bramrner, K. W. Antimicrob. Agents Chemothe. 1979, 15, 513.